Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

MENLO PARK, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital ...

Small Molecule CMO/CDMO Market Report On Size, Share, Competitive Landscape, And Trends Analysis. EINPresswire/ -- The small molecule CMO/CDMO sector is experiencing robust growth fueled by evolving ...

GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase 2 ...

The goal of a small-molecule drug discovery campaign is the development of chemical entities that fulfil the criteria of the target product profile for progression into clinical trials. This objective ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...

The Inflation Reduction Act represents a landmark shift in U.S. drug pricing regulation, introducing direct federal negotiation of drug prices for the first time. Notably, the IRA imposes earlier ...

Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...

Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...

Synfini, Inc. is revolutionizing small molecule drug discovery with its AI Cloud Foundry—a platform that integrates artificial intelligence, chemistry automation, and cloud-native workflows to ...